StemRIM (4599.T)
JPY 290.0
(-0.68%)
JPY 290.0
(-0.68%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -2.02 Billion JPY | -1301.07% |
| 2023 | 168.35 Million JPY | 108.64% |
| 2022 | -1.94 Billion JPY | -234.5% |
| 2021 | -582.44 Million JPY | -267.48% |
| 2020 | 347.76 Million JPY | 148.22% |
| 2019 | -721.21 Million JPY | -122.72% |
| 2018 | -323.82 Million JPY | -161.28% |
| 2017 | -123.93 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -513.38 Million JPY | 4.66% |
| 2024 Q4 | -503 Million JPY | 1.99% |
| 2024 Q2 | -538.46 Million JPY | -15.27% |
| 2024 Q1 | -467.14 Million JPY | 23.68% |
| 2023 Q2 | -503.16 Million JPY | 2.01% |
| 2023 FY | 168.35 Million JPY | 108.64% |
| 2023 Q1 | -513.5 Million JPY | -14.68% |
| 2023 Q4 | -612.09 Million JPY | -134.06% |
| 2023 Q3 | 1.79 Billion JPY | 457.16% |
| 2022 Q2 | -517.26 Million JPY | -5.43% |
| 2022 FY | -1.94 Billion JPY | -234.5% |
| 2022 Q4 | -447.75 Million JPY | 9.12% |
| 2022 Q3 | -492.68 Million JPY | 4.75% |
| 2022 Q1 | -490.6 Million JPY | -168.91% |
| 2021 FY | -582.44 Million JPY | -267.48% |
| 2021 Q4 | 711.96 Million JPY | 237.48% |
| 2021 Q3 | -517.87 Million JPY | -0.55% |
| 2021 Q2 | -515.01 Million JPY | -96.93% |
| 2021 Q1 | -261.52 Million JPY | -132.94% |
| 2020 FY | 347.76 Million JPY | 148.22% |
| 2020 Q4 | 793.83 Million JPY | 992.78% |
| 2020 Q3 | 72.64 Million JPY | 129.47% |
| 2020 Q2 | -246.5 Million JPY | 9.44% |
| 2020 Q1 | -272.2 Million JPY | -26.28% |
| 2019 FY | -721.21 Million JPY | -122.72% |
| 2019 Q4 | -215.56 Million JPY | 0.0% |
| 2018 FY | -323.82 Million JPY | -161.28% |
| 2017 FY | -123.93 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 626.563% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -283.744% |
| GNI Group Ltd. | 8.09 Billion JPY | 124.981% |
| Linical Co., Ltd. | 338.26 Million JPY | 697.754% |
| Trans Genic Inc. | 4.08 Million JPY | 49598.164% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | -40.617% |
| Soiken Holdings Inc. | -662.2 Million JPY | -205.344% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 1563.574% |
| AnGes, Inc. | -7.43 Billion JPY | 72.814% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | -56.971% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 71.889% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 1183.056% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -159.23% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | -75.385% |
| CanBas Co., Ltd. | -1.2 Billion JPY | -67.246% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | -148.889% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -524.726% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | -65.735% |
| Kidswell Bio Corporation | -1.42 Billion JPY | -42.186% |
| PeptiDream Inc. | 3.03 Billion JPY | 166.604% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | -4.307% |
| Ribomic Inc. | -1.02 Billion JPY | -97.415% |
| SanBio Company Limited | -2.64 Billion JPY | 23.525% |
| Healios K.K. | -3.82 Billion JPY | 47.11% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | -73.104% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | -35.741% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | -41.459% |
| CellSource Co., Ltd. | 923.14 Million JPY | 319.035% |
| FunPep Company Limited | -933.41 Million JPY | -116.624% |
| Kringle Pharma, Inc. | -854.15 Million JPY | -136.726% |
| Stella Pharma Corporation | -763.74 Million JPY | -164.747% |
| TMS Co., Ltd. | -960.04 Million JPY | -110.616% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | -78.936% |
| Cuorips Inc. | -632.18 Million JPY | -219.844% |
| K Pharma,Inc. | 260.33 Million JPY | 876.706% |
| Takara Bio Inc. | 1.48 Billion JPY | 236.622% |
| ReproCELL Incorporated | -31.41 Million JPY | -6336.416% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 7765.479% |
| StemCell Institute Inc. | 310.98 Million JPY | 750.2% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 1512.317% |
| CellSeed Inc. | -846.53 Million JPY | -138.856% |